United Therapeutics Corp
(NAS:UTHR)
$
360.87
-2.78 (-0.76%)
Market Cap: 16.11 Bil
Enterprise Value: 13.18 Bil
PE Ratio: 15.85
PB Ratio: 2.64
GF Score: 86/100 United Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 13, 2023 / 03:20PM GMT
Release Date Price:
$224.72
(-1.77%)
Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst
Great. Thanks everyone, and thanks always to the operators for making our lives so easy here. Very privileged and lucky to have the United Therapeutics team with us.
Dr. Martine Rothblatt; James; and Dewey are all on. Have gone to know them over many, many years, and it's always a pleasure to chat with them.
So please welcome all of you.
Martine A. Rothblatt
United Therapeutics Corporation - Founder, Chairman & CEO
Thank you, Hartaj. Great to talk with you as well.
Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst
Great. Thank you -- thank you, Martine. So Martine -- sorry, Dewey, I think you have something to say, I apologize.
Dewey Steadman
United Therapeutics Corporation - Head of IR
Yes. So today's presentation will contain forward-looking statements. So we encourage you to review our latest SEC filings, including Form 10-K and 10-Q
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot